Pharmaceutical Business review

P&G Q4 net sales rise

P&G’s net earnings were $2.51bn for the fourth quarter ended 30 June 2011, compared to $2.19bn, for the same period in 2010.

The company’s operating income was $3.29bn, compared to $2.95bn for the same period in 2010.

For the full year ended 30 June 2011, the company reported a net sales of $82.56bn, compared to $78.95bn for the same period in 2010.

The company has reported net earnings of $11.8bn for the full year ended 30 June 2011, as compared to $12.74bn for the same period in 2010.

P&G’s operating income was $15.82bn for the full year ended 30 June 2011, compared to $16.02bn for the same period in 2010.